Ultra-widefield imaging reveals early retinal risk in pediatric patients.
News|Articles|November 11, 2025
Retina experts reflect on how OCT transformed patient care
Author(s)Martin David Harp
Advertisement
Advertisement
Optical coherence tomography (OCT) has become so integral to retinal practice that it is nearly impossible to imagine the field without it. Once a novel imaging tool, OCT now serves as a diagnostic cornerstone and a daily guide for treatment decisions. Leading retina specialists recently reflected on how OCT reshaped patient care, efficiency, and the evolution of therapeutic strategies in ophthalmology.
Related to this article
Offline smartphone AI fundus screening detects diabetic retinopathy, glaucoma, and macular degeneration in one capture, delivering high accuracy for low-resource eye care.
Sura-vec is a 1-time investigational gene therapy designed to deliver sustained treatment in wet AMD, diabetic retinopathy and other chronic retinal conditions.
Study finds ChatGPT-5 overpredicts success after macular hole surgery—beating specialists on paper but missing failures.
The newly formed biotech will use the financing to push MMT-205, a bispecific antibody that directly activates Tie2 while inhibiting VEGF, toward IND-enabling studies, with first-in-human trials slated for 2027.
Atsena reported that, since enrollment opened in May 2026, it has already accrued approximately 10% of the pivotal cohort and expects the pace to accelerate as additional sites across North America and Europe are activated.
A balanced mix of AI-generated and smartphone-captured images eliminated the domain-specific failures seen with single-source training
Belite Bio has completed its rolling NDA submission to the FDA for tinlarebant, a potential first approved treatment for Stargardt disease type 1.
Advertisement
Advertisement